PENIS CARCINOMA

PENIS CARCINOMA was reported 38 times

PENIS CARCINOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 CCR5 Co-receptor Antagonist [EPC] 2 0.0009
1 Vitamin D Analog [EPC] 3 0.0002
2 Protease Inhibitor [EPC] 2 0.0000
3 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
4 Cytochrome P450 3A Inhibitor [EPC] 2 0.0000
5 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
6 Macrolide Antimicrobial [EPC] 1 0.0000
7 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2 0.0000
8 Tumor Necrosis Factor Blocker [EPC] 12 0.0000
9 Amide Local Anesthetic [EPC] 1 0.0000
10 Purine Antimetabolite [EPC] 1 0.0000
11 Aminosalicylate [EPC] 1 0.0000
12 Folate Analog Metabolic Inhibitor [EPC] 4 0.0000
13 P2Y12 Platelet Inhibitor [EPC] 1 0.0000
14 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
15 Proton Pump Inhibitor [EPC] 4 0.0000
16 Vitamin D [EPC] 2 0.0000
17 Vitamin B12 [EPC] 2 0.0000
18 Thiazide Diuretic [EPC] 1 0.0000
19 Vitamin C [EPC] 2 0.0000
20 Mood Stabilizer [EPC] 1 0.0000
21 Anti-epileptic Agent [EPC] 1 0.0000
22 Insulin Analog [EPC] 2 0.0000
23 Loop Diuretic [EPC] 2 0.0000
24 Alkylating Drug [EPC] 1 0.0000
25 Retinoid [EPC] 1 0.0000
26 Opioid Agonist [EPC] 1 0.0000
27 Osmotic Laxative [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
30 GLP-1 Receptor Agonist [EPC] 1 0.0000
31 Atypical Antipsychotic [EPC] 1 0.0000
32 Kinase Inhibitor [EPC] 1 0.0000
33 Corticosteroid [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 1 0.0000